Fennec Pharmaceuticals Inc. (FENC) is destined for greater heights as its last quarter sales were 0 K


Fennec Pharmaceuticals Inc. (NASDAQ: FENC) kicked off on September 21, 2022, at the price of $7.85, up 11.93% from the previous trading day. During the day, the shares moved up to $8.75 and dropped to $7.65 before settling in for the closing price of $7.63. Over the past 52 weeks, FENC has traded in a range of $3.82-$10.08.

Top 5 Tech Stocks Every Investor Should Buy Right Now

While finding excellent stocks with the potential for gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Tech Stocks Every Investor Should Buy Right Now", we have identified five tech stocks we believe could appreciate.

Sign up here to get your free report now.


While this was happening, its average annual earnings per share was recorded 12.70%. With a float of $21.59 million, this company’s outstanding shares have now reached $26.05 million.

In an organization with 10 employees, it is important to assess its efficiency.

Fennec Pharmaceuticals Inc. (FENC) Insider Updates

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Fennec Pharmaceuticals Inc. is 0.10%, while institutional ownership is 43.30%.

Fennec Pharmaceuticals Inc. (FENC) Performance Highlights and Predictions

In the latest quarterly report, which was put into the public domain on 3/30/2022, the organization reported -$0.14 earnings per share (EPS), higher than consensus estimate (set at -$0.14) by $0. This company achieved a return on equity of -76.36. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 12.70% per share during the next fiscal year.

Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Trading Performance Indicators

Take a look at Fennec Pharmaceuticals Inc.’s (FENC) current performance indicators. Last quarter, stock had a quick ratio of 5.10.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.67, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.24 in one year’s time.

Technical Analysis of Fennec Pharmaceuticals Inc. (FENC)

Let’s dig in a bit further. During the last 5-days, its volume was 0.6 million. That was better than the volume of 60491.0 it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 71.75%. Additionally, its Average True Range was 0.45.

During the past 100 days, Fennec Pharmaceuticals Inc.’s (FENC) raw stochastic average was set at 94.40%, which indicates a significant increase from 91.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 92.54% in the past 14 days, which was higher than the 51.49% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.84, while its 200-day Moving Average is $5.69. However, in the short run, Fennec Pharmaceuticals Inc.’s stock first resistance to watch stands at $8.98. Second resistance stands at $9.41. The third major resistance level sits at $10.08. If the price goes on to break the first support level at $7.88, it is likely to go to the next support level at $7.21. Assuming the price breaks the second support level, the third support level stands at $6.78.

Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Key Stats

The company with the Market Capitalisation of 226.40 million has total of 26,078K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -17,350 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -5,070 K.


Please enter your comment!
Please enter your name here